ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages

被引:467
作者
Oram, JF [1 ]
Lawn, RM
Garvin, MR
Wade, DP
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] CV Therapeut Inc, Palo Alto, CA 94304 USA
关键词
D O I
10.1074/jbc.M006738200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid-poor high density lipoprotein apolipoproteins remove cholesterol and phospholipids from cells by an active secretory pathway controlled by an ABC transporter called ABCA1, This pathway is induced by cholesterol and cAMP analogs in a cell-specific manner. Here we provide evidence that increased plasma membrane ABCA1 accounts for the enhanced apolipoprotein-mediated Lipid secretion from macrophages induced by cAMP analogs. Treatment of RAW264 macrophages with 8-bromo-cAMP caused parallel increases in apoA-I-mediated cholesterol efflux, ABCA1 mRNA and protein levels, incorporation of ABCA1 into the plasma membrane, and binding of apoA-I to cell-surface ABCA1, All of these parameters declined to near base-line values within 6 h after removal of 8-bromo-cAMP, indicating that ABCA1 is highly unstable and is degraded rapidly in the absence of inducer. Thus, ABCA1 is likely to be the cAMP-inducible apolipoprotein receptor that promotes removal of cholesterol and phospholipids from macrophages.
引用
收藏
页码:34508 / 34511
页数:4
相关论文
共 17 条
  • [1] ASSMAN G, 1995, METALOLIC MOL BASES, P2058
  • [2] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [3] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [4] Costet P, 2000, J BIOL CHEM, V275, P28240
  • [5] DEFECTIVE REMOVAL OF CELLULAR CHOLESTEROL AND PHOSPHOLIPIDS BY APOLIPOPROTEIN-A-I IN TANGIER DISEASE
    FRANCIS, GA
    KNOPP, RH
    ORAM, JF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 78 - 87
  • [6] Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
    Langmann, T
    Klucken, J
    Reil, M
    Liebisch, G
    Luciani, MF
    Chimini, G
    Kaminski, WE
    Schmitz, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 29 - 33
  • [7] The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
    Lawn, RM
    Wade, DP
    Garvin, MR
    Wang, XB
    Schwartz, K
    Porter, JG
    Seilhamer, JJ
    Vaughan, AM
    Oram, JF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (08) : R25 - R31
  • [8] High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
    McNeish, J
    Aiello, RJ
    Guyot, D
    Turi, T
    Gabel, C
    Aldinger, C
    Hoppe, KL
    Roach, ML
    Royer, LJ
    de Wet, J
    Broccardo, C
    Chimini, G
    Francone, OL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) : 4245 - 4250
  • [9] REGULATION OF HIGH-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY IN CULTURED HUMAN-SKIN FIBROBLASTS AND HUMAN ARTERIAL SMOOTH-MUSCLE CELLS
    ORAM, JF
    BRINTON, EA
    BIERMAN, EL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) : 1611 - 1621
  • [10] Oram JF, 1999, J LIPID RES, V40, P1769